clarithromycin has been researched along with Carcinoma, Lewis Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Mori, K; Narita, N; Sakamoto, S; Sawaki, M; Teramoto, M; Tsujimoto, M; Ueta, K | 1 |
| Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Narita, N; Sakamoto, M; Sawaki, M; Ueda, K; Yoshimoto, E | 1 |
2 other study(ies) available for clarithromycin and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
[Evaluation of BRM (biological response modifier) action of clarithromycin (CAM)--effect on cytokine expression in a mouse lung cancer model].
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Lewis Lung; Clarithromycin; Cytokines; Female; Immunologic Factors; Mice; Mice, Inbred C57BL; RNA, Messenger | 1998 |
[Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Killer Cells, Natural; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Middle Aged | 1998 |